David Gittings
Overview
Explore the profile of David Gittings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bradbury S, Gittings D, Schenk S
Psychopharmacology (Berl)
. 2012 May;
223(4):389-99.
PMID: 22562523
Rationale: Acute exposure to (±) 3, 4-methylenedioxymethamphetamine (MDMA) produces hyperlocomotion that is preferentially expressed in the periphery of closed chambers. Following repeated administration, however, a sensitized hyperlocomotor response is preferentially...
2.
Schenk S, Hely L, Gittings D, Lake B, Daniela E
Drug Alcohol Depend
. 2008 May;
96(3):249-55.
PMID: 18472230
Exposure to self-administered drugs is sufficient to produce drug-seeking in animal models. In many cases priming injections of drugs that share discriminative stimulus properties with the self-administered drug also can...
3.
Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash D
Eur J Neurosci
. 2007 Nov;
26(11):3229-36.
PMID: 18005064
3,4-Methylenedioxymethamphetamine (MDMA) self-administration has been shown in animals with extensive drug histories, but only a small number of studies have examined high rates of responding maintained by MDMA in previously...
4.
Brennan K, Lake B, Hely L, Jones K, Gittings D, Colussi-Mas J, et al.
Behav Pharmacol
. 2007 Nov;
18(8):785-90.
PMID: 17989516
The ability of benzylpiperazine (BZP) to substitute for cocaine and to initiate self-administration in drug-naive subjects was assessed to determine whether BZP has abuse liability. Further, the effects of a...
5.
Smith J, Harper D, Gittings D, Abernethy D
Brain Cogn
. 2007 Mar;
64(2):130-43.
PMID: 17343966
The present research sought to investigate the role of the basal ganglia in timing of sub- and supra-second intervals via an examination of the ability of people with Parkinson's disease...
6.
Daniela E, Gittings D, Schenk S
Behav Neurosci
. 2006 Oct;
120(5):1144-50.
PMID: 17014264
There has been some controversy in the literature concerning the ability of +/-3,4 methylenedioxymethamphetamine (MDMA) to reinforce operant responding in rats. In the present study, operant responding maintained by intravenous...
7.
Schenk S, Gittings D, Johnstone M, Daniela E
Psychopharmacology (Berl)
. 2003 May;
169(1):21-7.
PMID: 12774185
Rationale: +/-3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") use is increasing around the globe but there is a paucity of studies examining the abuse liability of this drug. Objectives: The ability of drugs to...